How can we improve esophageal cancer 5 year survival rates?
Research from the Medical University of South Carolina Hollings Cancer Center (SC, USA) points to a new way to exploit the metabolic Achilles’ heel in cancer-glutamine addiction. With these findings, researchers hope to develop treatments that can target drug-resistant esophageal cancer cells.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
- Connect and collaborate with other members
- Post about your own research, share your take on key topics and more